title: An open-label study on long-term outcomes of bosentan for treating ulcers in thromboangiitis obliterans (Buerger's disease).
authors.affiliation: Angiology and Vascular Surgery Department, Hospital Universitario Getafe, Madrid, Spain. Electronic address: deharojoaquin@yahoo.es.
authors.forename: Joaquin
authors.initials: J
authors.lastname: De Haro
authors.affiliation: Angiology and Vascular Surgery Department, Hospital Universitario Getafe, Madrid, Spain.
authors.forename: Silvia
authors.initials: S
authors.lastname: Bleda
authors.affiliation: Angiology and Vascular Surgery Department, Hospital Universitario Getafe, Madrid, Spain.
authors.forename: Francisco
authors.initials: F
authors.lastname: Acin
mesh_terms: D000328:Adult; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012883:Skin Ulcer / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan
keywords: Bosentan; Buerger disease; Long-term effect